<--- Back to Details
First PageDocument Content
3 / 4-Diaminopyridine / Pyridines / Lambert–Eaton myasthenic syndrome / BioMarin Pharmaceutical / Small-cell carcinoma / NHS Constitution for England / National Health Service / Scottish Medicines Consortium / NHS Scotland / Medicine / Health / Paraneoplastic syndromes
Date: 2013-08-13 12:09:51
3
4-Diaminopyridine
Pyridines
Lambert–Eaton myasthenic syndrome
BioMarin Pharmaceutical
Small-cell carcinoma
NHS Constitution for England
National Health Service
Scottish Medicines Consortium
NHS Scotland
Medicine
Health
Paraneoplastic syndromes

Add to Reading List

Source URL: www.england.nhs.uk

Download Document from Source Website

File Size: 204,67 KB

Share Document on Facebook

Similar Documents

Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013

Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013

DocID: 18C8i - View Document

The fact sheets have been adapted from material originally prepared by MDA USA with their kind permission. We are grateful for providing this valuable and informative material Facts About Myasthenia Gravis Myasthenia Gra

The fact sheets have been adapted from material originally prepared by MDA USA with their kind permission. We are grateful for providing this valuable and informative material Facts About Myasthenia Gravis Myasthenia Gra

DocID: UGvv - View Document

PDF Document

DocID: PIDE - View Document

Facts About  Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome & Congenital Myasthenic Syndromes

Facts About Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome & Congenital Myasthenic Syndromes

DocID: D89s - View Document

Facts About  Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome & Congenital Myasthenic Syndromes

Facts About Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome & Congenital Myasthenic Syndromes

DocID: hpbv - View Document